|
| 36738870 | Informative missingness: What can we learn from patterns in missing laboratory data in the electronic health record? | J Biomed Inform | 2023 |
| 36738870 | Informative missingness: What can we learn from patterns in missing laboratory data in the electronic health record? | J Biomed Inform | 2023 |
| 37490472 | A retrospective cohort analysis leveraging augmented intelligence to characterize long COVID in the electronic health record: A precision medicine framework. | PLOS Digit Health | 2023 |
| 37490472 | A retrospective cohort analysis leveraging augmented intelligence to characterize long COVID in the electronic health record: A precision medicine framework. | PLOS Digit Health | 2023 |
| 34923427 | Vaccination Against SARS-CoV-2 in Neuroinflammatory Disease: Early Safety/Tolerability Data. | Mult Scler Relat Disord | 2022 |
| 35768548 | International electronic health record-derived post-acute sequelae profiles of COVID-19 patients. | NPJ Digit Med | 2022 |
| 36283322 | Impact of resilience, social support, and personality traits in patients with neuroinflammatory diseases during the COVID-19 pandemic. | Mult Scler Relat Disord | 2022 |
| 35738646 | Changes in laboratory value improvement and mortality rates over the course of the pandemic: an international retrospective cohort study of hospitalised patients infected with SARS-CoV-2. | BMJ Open | 2022 |
| 36273240 | A semi-supervised adaptive Markov Gaussian embedding process (SAMGEP) for prediction of phenotype event times using the electronic health record. | Sci Rep | 2022 |
| 36203554 | Impact of the COVID-19 Pandemic on Personal Networks and Neurological Outcomes of People with Multiple Sclerosis: A Case-Control Cross-sectional and Longitudinal Analysis. | medRxiv | 2022 |
| 35780727 | The impact of socioeconomic status on subsequent neurological outcomes in multiple sclerosis. | Mult Scler Relat Disord | 2022 |
| 35350202 | Distinguishing Admissions Specifically for COVID-19 from Incidental SARS-CoV-2 Admissions: A National EHR Research Consortium Study. | medRxiv | 2022 |
| 35849686 | Predicting Multiple Sclerosis Outcomes During the COVID-19 Stay-at-home Period: Observational Study Using Passively Sensed Behaviors and Digital Phenotyping. | JMIR Ment Health | 2022 |
| 35598225 | Patterns of Utilization and Expenditure Across Multiple Sclerosis Disease-Modifying Therapies: A Retrospective Cohort Study Using Claims Data from a Commercially Insured Population in the United States, 2010-2019. | Neurol Ther | 2022 |
| 34923427 | Vaccination Against SARS-CoV-2 in Neuroinflammatory Disease: Early Safety/Tolerability Data. | Mult Scler Relat Disord | 2022 |
| 35134623 | Association of personality traits with physical function, cognition, and mood in multiple sclerosis. | Mult Scler Relat Disord | 2022 |
| 35016114 | Worsening physical functioning in patients with neuroinflammatory disease during the COVID-19 pandemic. | Mult Scler Relat Disord | 2022 |
| 35158446 | Temporal trends of multiple sclerosis disease activity: Electronic health records indicators. | Mult Scler Relat Disord | 2022 |
| 35738646 | Changes in laboratory value improvement and mortality rates over the course of the pandemic: an international retrospective cohort study of hospitalised patients infected with SARS-CoV-2. | BMJ Open | 2022 |
| 35350202 | Distinguishing Admissions Specifically for COVID-19 from Incidental SARS-CoV-2 Admissions: A National EHR Research Consortium Study. | medRxiv | 2022 |
| 35768548 | International electronic health record-derived post-acute sequelae profiles of COVID-19 patients. | NPJ Digit Med | 2022 |
| 35598225 | Patterns of Utilization and Expenditure Across Multiple Sclerosis Disease-Modifying Therapies: A Retrospective Cohort Study Using Claims Data from a Commercially Insured Population in the United States, 2010-2019. | Neurol Ther | 2022 |
| 35780727 | The impact of socioeconomic status on subsequent neurological outcomes in multiple sclerosis. | Mult Scler Relat Disord | 2022 |
| 35849686 | Predicting Multiple Sclerosis Outcomes During the COVID-19 Stay-at-home Period: Observational Study Using Passively Sensed Behaviors and Digital Phenotyping. | JMIR Ment Health | 2022 |
| 36273240 | A semi-supervised adaptive Markov Gaussian embedding process (SAMGEP) for prediction of phenotype event times using the electronic health record. | Sci Rep | 2022 |
| 36203554 | Impact of the COVID-19 Pandemic on Personal Networks and Neurological Outcomes of People with Multiple Sclerosis: A Case-Control Cross-sectional and Longitudinal Analysis. | medRxiv | 2022 |
| 36283322 | Impact of resilience, social support, and personality traits in patients with neuroinflammatory diseases during the COVID-19 pandemic. | Mult Scler Relat Disord | 2022 |
| 35016114 | Worsening physical functioning in patients with neuroinflammatory disease during the COVID-19 pandemic. | Mult Scler Relat Disord | 2022 |
| 35158446 | Temporal trends of multiple sclerosis disease activity: Electronic health records indicators. | Mult Scler Relat Disord | 2022 |
| 35134623 | Association of personality traits with physical function, cognition, and mood in multiple sclerosis. | Mult Scler Relat Disord | 2022 |
| 34479112 | Myelin oligodendrocyte glycoprotein (MOG) antibody-mediated disease: The difficulty of predicting relapses. | Mult Scler Relat Disord | 2021 |
| 33626237 | Leveraging electronic health records data to predict multiple sclerosis disease activity. | Ann Clin Transl Neurol | 2021 |
| 33616290 | Manifestations and impact of the COVID-19 pandemic in neuroinflammatory diseases. | Ann Clin Transl Neurol | 2021 |
| 33564777 | International Comparisons of Harmonized Laboratory Value Trajectories to Predict Severe COVID-19: Leveraging the 4CE Collaborative Across 342 Hospitals and 6 Countries: A Retrospective Cohort Study. | medRxiv | 2021 |
| 33655281 | Multinational Prevalence of Neurological Phenotypes in Patients Hospitalized with COVID-19. | medRxiv | 2021 |
| 34783826 | Comparison of Dimethyl Fumarate vs Fingolimod and Rituximab vs Natalizumab for Treatment of Multiple Sclerosis. | JAMA Netw Open | 2021 |
| 34889759 | Authorship Correction: International Changes in COVID-19 Clinical Trajectories Across 315 Hospitals and 6 Countries: Retrospective Cohort Study. | J Med Internet Res | 2021 |
| 34646227 | Applying Deep Learning to Accelerated Clinical Brain Magnetic Resonance Imaging for Multiple Sclerosis. | Front Neurol | 2021 |
| 34479112 | Myelin oligodendrocyte glycoprotein (MOG) antibody-mediated disease: The difficulty of predicting relapses. | Mult Scler Relat Disord | 2021 |
| 33655281 | Multinational Prevalence of Neurological Phenotypes in Patients Hospitalized with COVID-19. | medRxiv | 2021 |
| 33626237 | Leveraging electronic health records data to predict multiple sclerosis disease activity. | Ann Clin Transl Neurol | 2021 |
| 33564777 | International Comparisons of Harmonized Laboratory Value Trajectories to Predict Severe COVID-19: Leveraging the 4CE Collaborative Across 342 Hospitals and 6 Countries: A Retrospective Cohort Study. | medRxiv | 2021 |
| 33616290 | Manifestations and impact of the COVID-19 pandemic in neuroinflammatory diseases. | Ann Clin Transl Neurol | 2021 |
| 34889759 | Authorship Correction: International Changes in COVID-19 Clinical Trajectories Across 315 Hospitals and 6 Countries: Retrospective Cohort Study. | J Med Internet Res | 2021 |
| 34646227 | Applying Deep Learning to Accelerated Clinical Brain Magnetic Resonance Imaging for Multiple Sclerosis. | Front Neurol | 2021 |
| 34783826 | Comparison of Dimethyl Fumarate vs Fingolimod and Rituximab vs Natalizumab for Treatment of Multiple Sclerosis. | JAMA Netw Open | 2021 |
| 32361145 | Automated ICD coding via unsupervised knowledge integration (UNITE). | Int J Med Inform | 2020 |
| 32361145 | Automated ICD coding via unsupervised knowledge integration (UNITE). | Int J Med Inform | 2020 |
| 32769139 | Association of social network structure and physical function in patients with multiple sclerosis. | Neurology | 2020 |
| 32817202 | Phenome-wide examination of comorbidity burden and multiple sclerosis disease severity. | Neurol Neuroimmunol Neuroinflamm | 2020 |